Rapid Identification of Major Escherichia coli Sequence Types Causing Urinary Tract and Bloodstream Infections

被引:122
作者
Doumith, M. [1 ]
Day, M. [1 ]
Ciesielczuk, H. [1 ,2 ]
Hope, R. [1 ]
Underwood, A. [1 ]
Reynolds, R. [3 ]
Wain, J. [4 ]
Livermore, D. M. [1 ,4 ]
Woodford, N. [1 ,2 ]
机构
[1] Publ Hlth England, London, England
[2] Univ London, Barts & London Sch Med & Dent, Blizard Inst, Antimicrobial Res Grp,Ctr Immunol & Infect Dis, London, England
[3] Southmead Hosp, Dept Med Microbiol, Bristol, Avon, England
[4] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England
关键词
ANTIMICROBIAL RESISTANCE; NON-SUSCEPTIBILITY; EPIDEMIOLOGY; COMMUNITY; UK; ENTEROBACTERIACEAE; DIVERSITY; STRAINS;
D O I
10.1128/JCM.02562-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Escherichia coli sequence types (STs) 69, 73, 95, and 131 are collectively responsible for a large proportion of E. coli urinary tract and bloodstream infections, and they differ markedly in their antibiotic susceptibilities. Here, we describe a novel PCR method to rapidly detect and distinguish these lineages. Three hundred eighteen published E. coli genomes were compared in order to identify signature sequences unique to each of the four major STs. The specificities of these sequences were assessed in silico by seeking them in an additional 98 genomes. A PCR assay was designed to amplify size-distinguishable fragments unique to the four lineages and was validated using 515 E. coli isolates of known STs. Genome comparisons identified 22 regions ranging in size from 335 bp to 26.5 kb that are unique to one or more of the four predominant E. coli STs, with two to 10 specific regions per ST. These regions predominantly harbor genes encoding hypothetical proteins and are within or adjacent to prophage sequences. Most (13/22) were highly conserved (>96.5% identity) in the genomes of their respective ST. The new assay correctly identified all 142 representatives of the four major STs in the validation set (n = 515), with only two ST12 isolates misidentified as ST95. Compared with MLST, the assay has 100% sensitivity and 99.5% specificity. The rapid identification of major extraintestinal E. coli STs will benefit future epidemiological studies and could be developed to tailor antibiotic therapy to the different susceptibilities of these dominant lineages.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 24 条
  • [1] Clonal Composition and Community Clustering of Drug-Susceptible and -Resistant Escherichia coli Isolates from Bloodstream Infections
    Adams-Sapper, Sheila
    Binh An Diep
    Perdreau-Remington, Francoise
    Riley, Lee W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 490 - 497
  • [2] The Clonal Distribution and Diversity of Extraintestinal Escherichia coli Isolates Vary According to Patient Characteristics
    Banerjee, Ritu
    Johnston, Brian
    Lohse, Christine
    Chattopadhyay, Sujay
    Tchesnokova, Veronika
    Sokurenko, Evgeni V.
    Johnson, James R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 5912 - 5917
  • [3] Trimmomatic: a flexible trimmer for Illumina sequence data
    Bolger, Anthony M.
    Lohse, Marc
    Usadel, Bjoern
    [J]. BIOINFORMATICS, 2014, 30 (15) : 2114 - 2120
  • [4] Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings
    Croxall, Gemma
    Hale, James
    Weston, Vivienne
    Manning, Georgina
    Cheetham, Phil
    Achtman, Mark
    McNally, Alan
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (11) : 2501 - 2508
  • [5] Epidemiology of urinary tract infections - Transmission and risk factors, incidence, and costs
    Foxman, B
    Brown, P
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (02) : 227 - +
  • [6] Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England
    Gibreel, Tarek M.
    Dodgson, Andrew R.
    Cheesbrough, John
    Fox, Andrew J.
    Bolton, Frederick J.
    Upton, Mathew
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (02) : 346 - 356
  • [7] Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12)
    Horner, C.
    Fawley, W.
    Morris, K.
    Parnell, P.
    Denton, M.
    Wilcox, M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (01) : 91 - 100
  • [8] Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains
    Jaureguy, Francoise
    Landraud, Luce
    Passet, Virginie
    Diancourt, Laure
    Frapy, Eric
    Guigon, Ghislaine
    Carbonnelle, Etienne
    Lortholary, Olivier
    Clermont, Olivier
    Denamur, Erick
    Picard, Bertrand
    Nassif, Xavier
    Brisse, Sylvain
    [J]. BMC GENOMICS, 2008, 9 (1)
  • [9] Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
    Johnson, James R.
    Tchesnokova, Veronika
    Johnston, Brian
    Clabots, Connie
    Roberts, Pacita L.
    Billig, Mariya
    Riddell, Kim
    Rogers, Peggy
    Qin, Xuan
    Butler-Wu, Susan
    Price, Lance B.
    Aziz, Maliha
    Nicolas-Chanoine, Marie-Helene
    DebRoy, Chitrita
    Robicsek, Ari
    Hansen, Glen
    Urban, Carl
    Platell, Joanne
    Trott, Darren J.
    Zhanel, George
    Weissman, Scott J.
    Cookson, Brad T.
    Fang, Ferric C.
    Limaye, Ajit P.
    Scholes, Delia
    Chattopadhyay, Sujay
    Hooper, David C.
    Sokurenko, Evgeni V.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (06) : 919 - 928
  • [10] Extraintestinal pathogenic Escherichia coli:: "The other bad E coli"
    Johnson, JR
    Russo, TA
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 139 (03): : 155 - 162